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Chronic cocaine administration regulates the expression of several proteins related to
dopaminergic signaling and synaptic function in the mesocorticolimbic pathway, including
the prefrontal cortex. Functional abnormalities in the prefrontal cortex are hypothesized to
be due in part to the expression of proteins involved in dopamine signaling and plastic-
ity. Adult male rhesus monkeys self-administered cocaine (i.v.) under limited (n=4) and
extended access conditions (n= 6).The abundance of surrogate markers of dopamine sig-
naling and plasticity in the dorsolateral prefrontal cortex (DLPFC), orbitofrontal cortex (OFC),
and anterior cingulate cortex (ACC) were examined: glycosylated and non-glycosylated
forms of the dopamine transporter (efficiency of dopamine transport), tyrosine hydrox-
ylase (TH; marker of dopamine synthesis) and phosphorylated TH at Serine 30 and 40
(markers of enzyme activity), extracellular signal-regulated kinase 1 and 2 (ERK1 and ERK
2), and phosphorylated ERK1 and ERK2 (phosphorylatesTH Serine 31; markers of synaptic
plasticity), and markers of synaptic integrity, spinophilin and post-synaptic density pro-
tein 95 (roles in dopamine signaling and response to cocaine). Extended cocaine access
increased non-glycosylated and glycosylated DAT in DLPFC and OFC. While no differences
in TH expression were observed between groups for any of the regions, extended access
induced significant elevations in pTHSer31 in all regions. In addition, a slight but significant
reduction in phosphorylated pTHSer40 was found in the DLPFC. Phosphorylated ERK2 was
increased in all regions; however, pERK1 was decreased in ACC and OFC but increased in
DLPFC. PSD-95 was increased in the OFC but not in DLPFC or ACC. Furthermore, extended
cocaine self-administration elicited significant increases in spinophilin protein expression in
all regions. Results from the study provide insight into the biochemical alterations occurring
in primate prefrontal cortex.
Keywords: cocaine, dopamine, orbitofrontal cortex, anterior cingulate cortex, dorsolateral prefrontal cortex, rhesus
monkey
INTRODUCTION
Cocaine abuse is characterized in part by short-term and long-
term neuroadaptations in brain regions that affect subsequent
intake, withdrawal, relapse, and cognition. The majority of non-
human research conducted in this area has focused on alterations
in the mesolimbic dopamine system that mediates motivational
processes (1). More recently, the involvement of prefrontal corti-
cal regions in cocaine addiction has received increasing attention.
The prefrontal cortex is generally regarded as a principle neural
substrate of executive cognition (2–8). The dorsolateral prefrontal
cortex (DLPFC) is generally associated with planning, organizing,
and modifying motor output, sensory integration, and working
memory, the orbitofrontal cortex (OFC) with sensory integration,
Abbreviations: ACC, anterior cingulate cortex; DLPFC, dorsolateral prefrontal cor-
tex; ERK, extracellular signal-regulated kinase; OFC, orbitofrontal cortex; PSD-95,
post-synaptic density protein 95 kDa; TH, tyrosine hydroxylase.
reward salience and adaptive learning, and the anterior cingulate
cortex (ACC) with error detection, attention, and regulation of
emotional responses.
Several studies clearly demonstrate prefrontal cortical alter-
ations following chronic cocaine use that manifest as changes in
various cognitive deficits. Cocaine addicts exhibit deficits in behav-
ioral inhibition and attentional shifting that are qualitatively simi-
lar to individuals who have suffered damage to prefrontal regions.
Abstinent cocaine users exhibit several impairments of cognition
that are associated with functional alterations in the prefrontal
cortex including (1) impairment of decision making and execu-
tive control associated with increased activation of the OFC (9, 10),
(2) impairment of visuo-spatial working memory and sustained
attention associated with decreased activation of the anterior cin-
gulate and DLPFC (11, 12), (3) increased delayed discounting
associated with decreased activation of the prefrontal and ante-
rior cingulate cortices (13), (4) increased reactivity to audio-visual
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cues associated with activation of the anterior cingulate and dor-
solateral prefrontal cortices (14–17), and (5) lower sensitivity to
rewards associated with decreased activation of the orbitofrontal
and prefrontal cortex (18). The neurobiological alterations in con-
junction with the associated cognitive deficits likely undermine
the ability of the cocaine user to abstain from subsequent drug
intake and may serve as biological impediment to treatment. Thus,
understanding the long-term effects of cocaine use is critical to
developing medicinal and psychotherapeutic interventions that
will attenuate or possibly reverse the neuropathological effects of
cocaine.
Current understanding of stimulant-induced neurobi-
ological alterations (including expression and functional
genomics/proteomics, epigenetic modifications, etc.) is based pre-
dominantly on rodent models of human drug intake. The direct
determination of protein expression status and factors regulat-
ing protein expression in primate brain have been lacking, yet are
essential for understanding the neuropathology of cocaine use in
humans. The use of a non-human primate model of cocaine abuse
enables a clear and clinically relevant characterization of behav-
ioral and biochemical changes associated with chronic cocaine
use in a well-controlled laboratory setting. Moreover, non-human
primate cortex exhibits significant anatomical and biochemical
similarities with human cortex that facilitate the translation of
findings to humans (19–22).
Dopaminergic signaling within the mesocorticolimbic pathway
serves as a principal substrate for the reinforcing effects (REFS) of
abused drugs and is critically involved in cognition and informa-
tion processing (23–28). Dopamine afferents are found in high
densities in the OFC, DLPFC, and ACC) (29, 30) arising from the
dorsal aspects of the three mesencephalic dopamine cell groups
(31). The origins of the projections and their topography are
essentially the same in macaque monkey and human (32).
The present study characterized fundamental biochemical
adaptations in prefrontal cortical brain regions of rhesus mon-
keys following limited access and extended access conditions of
cocaine self-administration by assessing the expression of specific
markers of dopamine signaling and dopamine mediated plastic-
ity. The dopamine transporter is the principal mechanism for
removing dopamine from the synaptic cleft and a primary target
for cocaine’s REFS. DAT activity is dependent upon the pro-
tein’s glycosylation status, with glycosylated DAT more abundantly
expressed at the cell surface and more efficient in transporting
dopamine (33, 34). Previous studies have demonstrated elevated
DAT protein levels in the prefrontal cortex following chronic
cocaine self-administration in rats (35); however, no studies to
date have assessed glycosylation states of DAT following cocaine
self-administration. We hypothesize glycosylated DAT levels will
be increased following cocaine self-administration. Native and
phosphorylation states of tyrosine hydroxylase (TH) will also be
assessed. TH is the rate-limiting enzyme in dopamine synthe-
sis and therefore the principal regulator of cytosolic dopamine
levels. Cocaine-induced regulation of dopamine is well docu-
mented in the ventral tegmental area and the nucleus accumbens
in rodent models with increases, decreases or no change reported
depending on the dosing and treatment regimen (36–41). In
the rodent PFC, TH levels are increased following experimenter
administered cocaine (36), while levels are not changed following
cocaine self-administration (35). Phosphorylation of TH serine
residues 31 (pTHSer31) and 40 (pTHSer40) increase the enzyme’s
activity. Cocaine self-administration has been shown to increase
pTHSer31 (42) and decrease pTHSer40 levels in rodent striatum
(43). We hypothesize no change in native TH levels, increased
pTHSer31 and decreased pTHSer40 levels following cocaine self-
administration. Extracellular signal-regulated kinases 1 and 2
(ERK1/2) are involved in cocaine-induced synaptic plasticity (44)
and mediate the phosphorylation of TH at Serine 31 (45). We
hypothesize that increases in pTHSer31 will be accompanied by
concomitant increases in the phosphorylation of ERK1 and ERK2.
In addition, we hypothesize increased levels of spinophilin, a
synaptic scaffolding protein in dendritic spines, and decreased
levels of post-synaptic density protein 95 (PSD-95), a scaffolding
protein located in the post-synaptic density, as the name indi-
cates. Both proteins play distinct and important roles in dopamine
signaling and responses to psychomotor stimulant administration.
MATERIALS AND METHODS
SURGERY AND SELF-ADMINISTRATION PROCEDURES
Eighteen male adult rhesus monkeys (Macacamulatta) were singly
housed with standard enrichment, including social enrichment,
human interaction, variety in diet, and age appropriate objects
as dictated by the Animal Welfare Act and the Emory Univer-
sity Policy for Environmental Enhancement. Food and water were
available ad libitum. Animal care procedures strictly followed the
National institutes of Health Guide for the Care and Use of Lab-
oratory Animals and were approved by the Institutional Animal
Care and Use Committee of Emory University School of Medicine.
Ten subjects were surgically prepared with chronically
indwelling venous catheters using procedures described previ-
ously (46). Under appropriate anesthesia, either isoflurane alone
or ketamine in combination with diazepam, and under aseptic
conditions, one end of a silicone catheter was passed by way of a
jugular or femoral vein to the level of the right atrium and vena
cava, respectively. The distal end of the catheter was passed under
the skin and attached to a vascular access port (Access Technolo-
gies, Skokie, IL, USA) that remained subcutaneous in the center of
the back for easy access. The 0.25 ml unit was accessed during test-
ing with special right-angle Huber needles (Access Technologies,
Skokie, IL, USA) that minimize damage to the port membrane
and allow for repeated punctures over a year or more. Catheters
were flushed periodically with heparinized saline (0.9%). Daily
experimental sessions were conducted within a ventilated, sound-
attenuating chamber with each monkey seated in a standard pri-
mate chair of the type commercially available (Primate Products,
Redwood City, CA, USA). A panel equipped with a response lever
and stimulus lights was mounted on the front of the chair. The
vascular access port was connected via polyvinyl-chloride tubing
to a motor-drive syringe located outside the test chamber to yield a
precise injection volume of 2.0 ml during drug self-administration
experiments with dose determined by the concentration of drug
solution in the syringe. Experimental procedures were controlled
on-line by a microprocessor and electromechanical programing
systems, and data were monitored and recorded during daily
sessions.
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One group of four rhesus monkeys comprised the limited access
condition and was trained to self-administer cocaine by pressing
a response key while seated in a primate chair. Responding was
initiated using a 1-response fixed-ratio schedule (FR 1) so that
each response in the presence of a red light produced an intra-
venous drug injection and the brief illumination of a white light
followed by a timeout. The ratio value was increased gradually
as responding increased. When the schedule value reached FR 20,
drug injection no longer followed completion of each FR and,
instead, was arranged to follow an increasing number of FR com-
ponents. Ultimately, the schedule was a second-order schedule of
FR 20 components with drug injection following the first compo-
nent completed after 10 min had elapsed [FI 600 s (FR 20:S)]. A
2-s white light was presented upon completion of each FR 20 com-
ponent. Drug administration was accompanied by a change in the
stimulus light from red to white for 15 s, followed by a 1-min time-
out. Daily sessions consisted of five consecutive 10 min intervals.
The unit dose of cocaine remained constant at 0.1 mg/kg/injection
(46, 47). Use of this second-order procedure and limiting the daily
session to approximately 1 h enabled the standardization of total
drug intake to 0.5 mg/kg/session. Previously, we have reported
significant alterations in ionotropic glutamate receptor subunits
in the NAc from the limited access subjects used in the present
study (20).
A separate group of six monkeys was trained as described
above and composed the extended access group. The initial lim-
ited access condition as described above was then followed by
3 months of extended access conditions during which monkeys
had an opportunity 3 days per week to increase the amount of
cocaine self-administered. On extended access days, sessions began
with the second-order schedule, followed by two additional hours
on FR 20 schedule for total session duration of 3 h. During the
additional 2 h of extended access, a green stimulus light illumi-
nated the chamber and each FR 20 completed resulted in the
presentation of the 15-s white light and a 0.1 mg/kg infusion of
cocaine. Each infusion received was followed by a 60-s timeout.
Monkeys had the opportunity to take an additional 30 infusions
(3.0 mg/kg total) during the extended access condition in addition
to the 0.5 mg/kg available during the 1 h second-order schedule.
Behavioral data for the monkeys in the extended access group have
been reported previously (48).
TISSUE DISSECTION
Following completion of the drug self-administration studies,
monkeys were restrained with Telazol, given intravenous heparin
and then an overdose of intravenous sodium pentobarbital. Four
control monkeys were euthanized as described above. After the
confirmed absence of brain stem reflexes was established, the mon-
keys were transcardially perfuse with ice cold phosphate buffered
saline (PBS; pH 7.2–7.4), the brain was removed and placed in 4°C
PBS for 5 min.
Following euthanasia and removal of the brain, the prefrontal
cortex was dissected from the rest of the brain and the OFC
(Area 13), ACC (Area 24), and DLPFC (Area 46) were dissected as
described previously (49). The OFC dissection included the medial
and lateral aspects of the medial orbital sulcus located rostral to
the rostral end of the corpus callosum, and therefore included
Areas13a and 13m (50). The ACC was dissected from the rostral
pole of the corpus callosum and included tissue from the cingu-
late gyrus up to but not including the lower bank of the cingulate
sulcus, containing fields 24a and 24b. The DLPFC (Area 46) was
dissected from the banks of the principle sulcus midway along its
length.
PROTEIN ISOLATION AND FRACTIONATION
A steel mortar and pestle chilled in dry ice were used to pulver-
ize the frozen brain tissue into a dry homogenate in the pres-
ence of liquid nitrogen. Tissue proteins were fractionated into
membrane, nuclear, and cytosolic fractions as described previ-
ously (20, 22, 51, 52). Protein was quantified using the bicin-
choninic acid protein assay kit (Pierce Biotechnology) and equiv-
alent final protein concentrations of each sample were diluted in
Laemmli sample buffer, boiled at 95°C for 5 min, and subjected
to electrophoresis. Samples were separated on Tris-HCl SDS-
PAGE gels and transferred to nitrocellulouse membranes. Mem-
branes were blocked with Odyssey blocking buffer (Licor, Lin-
coln, Nebraska) and incubated with primary antibody overnight
at 4°C. Primary antibodies included anti-dopamine transporter
(Millipore, #AB2231, 1:1000), anti-TH (Sigma, #T1299, 1:5000),
anti-phospho-TH (pSer31) (Sigma, #SAB4300674, 1:1000), anti-
phospho-TH (pSer40) (Sigma, #T9573, 1:1000), anti-ERK1/2 (Cell
Signaling Technology, #4695, 1:1000), anti-phospho- ERK1/2 at
Thr202/204 (Cell Signaling Technology, #4370, 1:1000), anti-
spinophilin (Millipore, #06-852, 1:1000), and anti-PSD-95 (Mil-
lipore, #MAB-1596, 1:1000). Antibodies were visualized with flu-
orophore conjugated secondary antibodies. Blots were scanned
with the Licor Odyssey infrared scanner and signals were quanti-
fied with Odyssey software. Equal protein loading and efficiency
of transfer were confirmed by probing blots with a GAPDH
antibody (Millipore, #MAB-374, 1:500). Signal intensities for
proteins of interest were reported as percent control relative to
GAPDH.
DATA ANALYSIS
Background-subtracted intensity values for each sample were cal-
culated using Odyssey version 1.2 software. Data from each region
were analyzed using one way analysis of variance with treatment
as the factor and hybridization intensity relative to GAPDH as the
dependent variable. Post hoc analysis was performed using Tukey’s
test and the null hypothesis was rejected when P < 0.05.
RESULTS
BEHAVIORAL DATA
Once stable self-administration behavior was established under
the second-order schedule, subjects reliably obtained all sched-
uled injections during daily sessions. Cocaine self-administration
for subjects in the limited access and extended access groups
have been reported previously (20, 48). The average total
intake was 37.9± 4.6 mg/kg for the limited access group and
151.8± 24.3 mg/kg for the extended access group. For the lim-
ited access group, the average session intake was 0.46± 0.1 mg/kg
for the final three months of stable self-administration. For
the extended access group, the average session intake was
1.81± 0.5 mg/kg during the three months of extended access.
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WESTERN BLOT
Western blot analysis was performed on membrane (DAT) or
cytosolic protein fractions from individual monkeys in the Lim-
ited Access, Extended Access, and control groups to assess levels of
cocaine-regulated proteins.
Dopamine transporter
In the DLPFC, glycosylated dopamine transporter levels were
significantly increased in [F(2,17)= 24.92, P < 0.001] in the
Extended Access Group compared to Limited Access and Con-
trols. Similarly, non-glycosylated DAT levels were increased in the
extended access group compared to controls, but not to Limited
Access [F(2,17)= 5.334, P = 0.018]. Similar to the DLPFC, glyco-
sylated DAT levels in the OFC were significantly increased in the
Extended Access Group compared to Limited Access and Controls
in the OFC [F(2,17)= 44.44, P < 0.001]. Un-glycosylated DAT
levels in the OFC were increased in the extended access group com-
pared to Limited Access, and between Limited Access and controls
[F(2,17)= 25.072, P < 0.001]. No changes were observed in levels
of glycosylated DAT in the ACC; however, non-glycosylated DATA
levels were significantly greater in the Extended Access group com-
pared to Limited Access and controls [F(2,16)= 7.55, P = 0.006]
(Figure 1).
FIGURE 1 |Western blot analysis of glycosylated and non-glycosylated
dopamine transporter protein levels in prefrontal regions following
limited and extended access to cocaine self-administration. Membrane
fractions were isolated as described in the Section “Materials and
Methods” and 15µg were separated on 10% SDS-PAGE. Data are
expressed as mean (±SEM) of the percent of control values per amount of
protein loaded. Asterisks indicate a significant difference (P<0.05). Bottom
Panel: Representative bands from two subjects per group per region.
Tyrosine hydroxylase
While no significant difference was observed in TH levels, TH
phosphorylated at Serine 31 (pTHSer31) was elevated in the
Extended Access group compared to Controls [F(2,17)= 4.754,
P = 0.025] (Figure 2). Conversely, phosphorylation of serine 40
on TH (pTHSer40) was significantly decreased in the Extended
FIGURE 2 | Protein levels ofTH, pTHSer31, and pTHSer40 in prefrontal
cortical regions as a function of cocaine self-administration exposure
determined byWestern blot analysis. Cytosolic fractions were isolated as
described in the Section “Materials and Methods” and 10µg were
separated on 10% SDS-PAGE. Data are expressed as mean (±SEM) of the
percent of control values per amount of protein loaded. Asterisks indicate a
significant difference (P<0.05). Bottom Panel: Representative bands from
two subjects per group per region.
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FIGURE 3 | Protein levels of ERK1 and pERK1 in prefrontal regions
following limited and extended access to cocaine self-administration.
Cytosolic fractions were isolated as described in the Section “Materials and
Methods” and 10µg were separated on 10% SDS-PAGE. Data are
expressed as mean (±SEM) of the percent of control values per amount of
protein loaded. Asterisks indicate a significant difference (P<0.05). Bottom
Panel: Representative bands from two subjects per group per region.
Access group compared to Controls [F(2,17)= 8.86, P = 0.003]
(Figure 2). In the OFC, no significant differences were observed
in TH, pTHSer31, or pTHSer40 between the groups (Figures 2 and
3). Similarly, no significant differences were observed for TH or
pTHSer40 between the groups in the ACC. Levels of pTHSer31
were significantly increased in the Extended Access group com-
pared to Limited Access and controls [F(2,17)= 11.30,P < 0.001]
(Figure 2).
Extracellular signal-regulated kinase
ERK1 and ERK2 phosphorylate THSer31 among other proteins.
Whereas no changes were observed for ERK1 in the DLPFC
region, phosphorylated ERK1 levels were significantly greater in
the Extended Access group compared to controls [F(2,17)= 6.307,
P = 0.01]. Extended Access to cocaine-induced a significant
increase in ERK2 [F(2,17)= 5.623, P = 0.015] as well as phos-
phorylated ERK2 levels [F(2,17)= 6.40, P = 0.007] over control
values (Figure 4).
In the OFC, Extended Access to cocaine-induced a signifi-
cant increase in ERK1 [F(2,17)= 5.623, P = 0.015] compared
to control values. However, pERK1 levels were increased follow-
ing Limited Access compared to control levels, and significantly
FIGURE 4 | Protein levels of ERK2 and pERK2 in prefrontal regions
following limited and extended access to cocaine self-administration.
Cytosolic fractions were isolated as described in the Section “Materials and
Methods” and 10µg were separated on 10% SDS-PAGE. Data are
expressed as mean (±SEM) of the percent of control values per amount of
protein loaded. Asterisks indicate a significant difference (P<0.05). Bottom
Panel: Representative bands from two subjects per group per region.
less following Extended Access compared to Limited Access
[F(2,17)= 18.605, P < 0.001]. ERK2 levels were greater in the
Extended Access group compared to controls [F(2,17)= 20.075,
P < 0.001], while pERK2 levels were increased in the Limited
Access group compared to controls [F(2,17)= 5.185, P = 0.021]
(Figure 4).
In the ACC, Extended Access to cocaine-induced a significant
increase in ERK1 [F(2,17)= 39.53, P < 0.001] compared to Lim-
ited Access and control values. pERK1 levels were significantly
different between the groups [F(2,17)= 4.26, P = 0.034], how-
ever, post hoc analysis did not reveal the nature of the differences.
ERK2 levels were greater in the Extended Access group com-
pared to controls [F(2,17)= 6.19, P = 0.011], while pERK2 levels
were increased in the Limited Access and Extended Access groups
compared to controls [F(2,17)= 18.576, P < 0.001] (Figure 4).
Spinophilin and PSD-95
Levels of spinophilin and PSD-95 were assessed to determine
changes in dendritic spines and post-synaptic densities follow-
ing chronic cocaine self-administration. In the DLPFC, lev-
els of spinophilin were significantly increased in the Extended
Access compared to Limited Access and Controls [F(2,17)= 44.09,
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P = 0.001]. In the OFC, spinophilin levels were significantly
increased in the Extended Access compared to Limited Access and
Controls [F(2,17)= 38.12,P < 0.001]. Levels of spinophilin in the
ACC were significantly increased in the Extended Access com-
pared to Limited Access and Controls [F(2,17)= 21.58,P < 0.001]
(Figure 5).
No significant difference in the level of PSD-95 in the DLPFC
was observed between the groups. In contrast, Extended Access
to cocaine resulted in increased levels of PSD-95 compared to
controls in the OFC [F(2,16)= 11.20, P < 0.001], whereas no sig-
nificant difference in the level of PSD-95 was observed between
the groups in the ACC (Figure 6).
FIGURE 5 |Western blot analysis of spinophilin protein levels in
prefrontal regions following limited and extended access to cocaine
self-administration. Cytosolic fractions were isolated as described in the
Section “Materials and Methods” and 10µg were separated on 10%
SDS-PAGE. Data are expressed as mean (±SEM) of the percent of control
values per amount of protein loaded. Asterisks indicate a significant
difference (P<0.05). Bottom Panel: Representative bands from two
subjects per group per region.
FIGURE 6 |Western blot analysis of PSD-95 protein levels in prefrontal
regions following limited and extended access to cocaine
self-administration. Cytosolic fractions were isolated as described in the
Section “Materials and Methods” and 10µg were separated on 10%
SDS-PAGE. Data are expressed as mean (±SEM) of the percent of control
values per amount of protein loaded. Asterisks indicate a significant
difference (P<0.05). Bottom Panel: Representative bands from two
subjects per group per region.
DISCUSSION
The current results indicated that cocaine self-administration up-
regulated various aspects of dopamine transmission in the pre-
frontal cortex in a region specific manner. Significant increases
in non-glycosylated and glycosylated DAT were found in the
DLPFC and OFC following extended cocaine access. While no
differences in TH expression were observed between groups for
any of the regions, extended access induced significant elevations
in pTHSer31 in all regions. In addition, a slight but significant
reduction in phosphorylated pTHSer40 was found in the DLPFC.
pTHSer31 is phosphorylated by ERK1 and ERK2. Phosphorylated
ERK2 was increased in all three regions; however, pERK1 lev-
els were decreased in the ACC and OFC but increased in the
DLPFC. PSD-95, which interacts with the D1 receptor and DAT,
was increased in the OFC but not in the DLPFC or ACC. Fur-
thermore, extended cocaine self-administration elicited signifi-
cant increases in spinophilin protein expression in all regions.
These data support and expand the results of studies in humans
implicating dopaminergic dysregulation in cocaine abuse and pro-
vide molecular markers of prefrontal dysregulation in cocaine
addiction.
Cocaine abuse is characterized by uncontrollable drug-seeking
and drug-taking behaviors, increased use in the presence of nega-
tive consequences and inflexibility to make necessary adjustments
to decrease or cease drug use (53). In general, the actions of the
DLPFC, OFC, and parts of the ACC mediate behavioral control
and flexibility in decision-making processes, the same prefrontal
cortical areas dysregulated in cocaine addicts. Numerous studies
have shown that chronic cocaine abuse results in “hypofrontality”
as evidenced by decreased rates of glucose usage (4, 54, 55) and
disrupted cerebral blood flow (56–58).
Deficits in specific aspects of executive function that are accom-
panied by changes in prefrontal function (59). For example,
decreased response inhibition is accompanied by decreased acti-
vation of the ACC and DLPFC during GO-NOGO task per-
formance in cocaine abusers compared to controls (60), while
cocaine abusers exhibited poor performance on the Stroop task
that was accompanied by decreased glucose utilization in the
OFC (8). During tasks to assess updating activity and capacity,
cocaine abusers exhibited working memory hyper-activation of
the DLPFC whereas working memory load activation (capac-
ity) of the DLPFC was significantly lower in the cocaine group
compared to controls (61). When assessing the effect of memory
loading on response inhibition, Hester and Garavan found that
as memory load increased, response inhibition decreased and was
accompanied by decreased ACC activity in cocaine abusers (62).
With regard to cognitive flexibility, poor performance on atten-
tion switching tasks is associated with decreased OFC and ACC
activity in cocaine abusers (9, 11). In toto, these studies suggest
a neuroanatomical basis for cognitive dysfunction in addiction,
supporting a prominent role that such dysfunction may play in
prolonging abuse or predisposing users toward relapse.
While numerous studies have identified prefrontal cortical
regions associated with cocaine-induced cognitive dysfunction,
characterizing the biochemical bases of prefrontal dysregulation
associated with cocaine abuse has proven to be less straightfor-
ward. In a previous study in rhesus monkeys, a challenge infusion
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of cocaine following limited access self-administration increased
metabolic activity throughout the prefrontal cortex including the
DLPFC (Area 46), rostral superior frontal gyrus (Area 11), ven-
tral ACC (Area 24) with the most robust activation in the ventral
OFC (Area 13 and 47). Extended access was shown to induce
broader metabolic activity in the prefrontal cortex to include
rostral prefrontal cortex (Area 10), in addition to those areas acti-
vated during limited access, with the most prominent activation
in the DLPFC (63). The pattern of expanded involvement of pre-
frontal cortical domains as a function of cocaine exposure has also
been demonstrated in macaques using the 2-[14C]deoxyglucose
method (64–66). While metabolic activation studies have clearly
shown involvement of prefrontal cortical regions in cocaine abuse,
the biochemical basis for these changes remains uncertain. Given
the dense dopaminergic innervation, the laminar distribution and
densities of dopamine receptors in the DLPFC, OFC, and ACC and
the essential modulatory role of dopamine on circuits involved in
cognitive functions including working memory, response inhibi-
tion, set-shifting, and updating (23, 67, 68), it is reasonable to
propose that cocaine-induced alterations in dopamine transmis-
sion and signaling may have a significant impact on prefrontal
function and correspondingly on cognitive function.
The goal of the current study was to assess biochemical markers
of dopaminergic transmission/signaling and synaptic plasticity in
prefrontal regions following limited and extended access to cocaine
self-administration in rhesus monkeys. The dopamine transporter
serves as the principal mechanism for removal of the neuro-
transmitter from the synapse. Cocaine inhibition of dopamine
uptake leads to significant elevations of dopamine in the synap-
tic cleft an effect to which the reinforcing and behavioral effects
of cocaine are attributed (69–71). DAT function is dependent
upon the glycosylation status such that increased glycosylation
is related to increased membrane expression as well as increased
DA uptake. Non-glycosylated DAT is present at the membrane
surface and appears to be functional to some extent (33, 34).
In the present study, extended cocaine self-administration access
resulted in increased levels of glycosylated DAT in the DLPFC and
OFC and increased levels of non-glycosylated DAT in all three
regions. Comparably, DAT binding is increased in the striatum,
following chronic cocaine self-administration (3 months) (72) as
well as in the striata of human cocaine overdose victims (73–76).
The present results demonstrate that DAT abundance in primate
prefrontal cortex is sensitive to chronic blockade by cocaine and
suggest DAT glycosylation is another adaptive mechanism induced
by cocaine.
The enzymatic activity of TH, the rate-limiting enzyme of cate-
cholamine biosynthesis, is regulated by phosphorylation of serine
residues 31 and 40 in the N terminal regulatory domain that are
phosphorylated by a variety of kinases. THSer40 is phosphory-
lated by CAMP dependent protein kinase and to a lesser extent
by calcium-calmodulin kinase and is the primary generator of TH
activity. In addition, THSer40 phosphorylation relieves feedback
inhibition, in this case, from dopamine. THSer31 is phosphory-
lated by ERK1 and 2 and also increases TH activity but to a lesser
extent than THSer40 phosphorylation (45). Also, TH activity can be
regulated long term by an increase in protein synthesis, however,
we did not observe a change in TH levels in any of the prefrontal
regions assessed following limited or extended access cocaine self-
administration, similar to findings in the PFC of rats following
10 days of self-administration (35). Instead, we observed region
specific changes in the phosphorylation of THSer31 and THSer40.
In the DLPFC and ACC, levels of phosphorylated THSer31 were
elevated while in the DLPFC pTHSer40 was decreased following
extended access cocaine self-administration. Elevated pTHSer31
may reflect an increase in TH activity and dopamine synthesis,
albeit at a lower level of activity than pTHSer40 while decreases
in pTHSer40 likely reflect feedback inhibition of dopamine syn-
thesis as shown preciously in the NAc following chronic cocaine
self-administration in rats (43).
The MAPK/ERK pathway is a signaling cascade that is acti-
vated by neurotrophic factors and regulated by the Ras family
of GTPases. Activation of the pathway regulates the phospho-
rylation of various proteins, including THSer31 (45), as well as
transcription and translation of various molecules involved in
cognitive processes (77) and long-term synaptic changes (78–81).
In the present study, phosphorylation of THSer31 was increased
following extended cocaine access that was accompanied by con-
comitant changes in pERK1/ERK1 and pERK2/ERK2 levels in the
DLPFC. While similar increases were observed in pTHSer31 in
the ACC, there was a trend toward decreased pERK1/ERK lev-
els and a significant increase in pERK2/ERK2 levels following
extended access. Previous studies have indicated that ERK1 is
poorly phosphorylated in the brain and therefore possesses lit-
tle direct signaling capacity in vivo (80). Furthermore, ablation of
ERK1, as in ERK1 knockout mouse, resulted in a stimulus depen-
dent increase in ERK2 signaling due to an enhanced interaction
with MEK (79). Reduction of pERK1 and elevation of pERK2
suggests that THSer31 phosphorylation is being driven primar-
ily through ERK2 activity in the ACC. Interestingly, increased
ratios of pERK1/ERK1 and pERK2/ERK2 in the limited access
group did not correlate with increased THSer31 levels in the OFC.
The differences in ERK-dependent signaling responses amongst
the DLPFC, ACC, and OFC are interesting but not unexpected
as a previous study demonstrated regions specific changes in
ERK-dependent signaling in the accumbens, hippocampus, and
amygdala (79).
Synaptic plasticity is regulated by the expression and modifica-
tions of a variety of post-synaptic proteins, such as spinophilin and
PSD-95. Spinophilin is highly enriched in the majority of dendritic
spines and regulates the morphology and function of dendritic
spines (82). PSD-95 is a post-synaptic scaffolding protein that is
involved in the maturation and stability of excitatory synapses
(83). As such, spinophilin and PSD-95 serve as proxies for changes
in the abundance, size, and shape of dendritic spines and excitatory
synapses in the brain, respectively. Alterations in the abundance
of these proteins has been associated with changes in cognition
(84, 85) synaptic plasticity and development (86–89) as well as
cocaine exposure (90). In the present study, extend access cocaine
self-administration resulted in elevated levels of spinophilin in
all three cortical regions, while PSD-95 was only increased in
the OFC. Given the known functions of spinophilin, increased
levels likely reflect increased spine density and synaptic activity
(91) following extended cocaine access. The manner in which
cocaine induces such changes remains to be determined; however,
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a recent study has demonstrated that chronic activation of D1
and D2 receptors increase spine density and levels of spinophilin
expression in striatal medium spiny neurons (92) suggesting the
possibility of a similar mechanism in cortical neurons. The region
specific increase in PSD-95 in the OFC is particularly interest-
ing in light of the glutamatergic projections from this region to
the nucleus accumbens in primates. DAT knockout mice exhibit
reduced PSD-95 protein levels in the accumbens and targeted
deletion of PSD-95 enhances LTP in frontocortical-accumbal pro-
jections (93). Assuming similar relationships in the present study
(e.g., elevated DAT levels are correlated with increased PSD-95 lev-
els), it is reasonable to suggest that OFC frontocortical-accumbal
projections may exhibit reduced LTP and therefore a reduction in
prefrontal regulation of accumbal function. Dysfunction of OFC –
accumbal projections are thought to produce impulsivity such that
current behavior is dominated by previously conditioned behav-
iors that may be inappropriate for normal functioning (94) – as
seen in various pathological states such as addiction.
The current study provides insight into biochemical alterations
occurring in prefrontal cortical regions in primate brain as a
function of cocaine exposure. The changes in dopamine related
proteins in prefrontal regions might contribute to alterations in
the subjective experience and behavioral characteristics of chronic
cocaine abusers. Examination of the effects of cocaine on cognitive
functions as well as levels of receptor and transporter expres-
sion, the prefrontal circuitry primarily affected and the expression
of dopamine receptor interacting proteins and proteins involved
in signal transduction in the non-human primates will be fun-
damental to ascertaining the molecular pathology of prefrontal
dysregulation in cocaine addiction.
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